Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses

Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses

Abstract Nanobodies, single-domain antibodies derived from variable domain of camelid or shark heavy-chain antibodies, have unique properties with small size, strong binding affinity, easy construction in versatile formats, high neutralizing activity, protective efficacy, and manufactural capacity o...

Full description

Bibliographic Details
Main Authors: Yang Yang, Fang Li, Lanying Du
Format: Article
Language:English
Published: BMC 2024-05-01
Series:Journal of Nanobiotechnology
Subjects:
Pathogenic coronaviruses
SARS-CoV-2
SARS-CoV
MERS-CoV
Spike protein
Receptor-binding domain
Online Access:https://doi.org/10.1186/s12951-024-02573-7

Internet

https://doi.org/10.1186/s12951-024-02573-7

Similar Items